A hypothesis-free bridging of disease dynamics and non-pharmaceutical policies

From MaRDI portal
Publication:2127658

DOI10.1007/S11538-022-01012-8zbMATH Open1486.92295arXiv2112.04106OpenAlexW4200630808WikidataQ113900059 ScholiaQ113900059MaRDI QIDQ2127658FDOQ2127658


Authors: Xiunan Wang, Hao Wang, Pouria Ramazi, Kyeongah Nah, M. A. Lewis Edit this on Wikidata


Publication date: 21 April 2022

Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)

Abstract: Accurate prediction of the number of daily or weekly confirmed cases of COVID-19 is critical to the control of the pandemic. Existing mechanistic models nicely capture the disease dynamics. However, to forecast the future, they require the transmission rate to be known, limiting their prediction power. Typically, a hypothesis is made on the form of the transmission rate with respect to time. Yet the real form is too complex to be mechanistically modeled due to the unknown dynamics of many influential factors. We tackle this problem by using a hypothesis-free machine-learning algorithm to estimate the transmission rate from data on non-pharmaceutical policies, and in turn forecast the confirmed cases using a mechanistic disease model. More specifically, we build a hybrid model consisting of a mechanistic ordinary differential equation (ODE) model and a generalized boosting model (GBM). To calibrate the parameters, we develop an "inverse method" that obtains the transmission rate inversely in time from the other variables in the ODE model and then feed it into the GBM to connect with the policy data. The resulting model forecasted the number of daily confirmed cases up to 35 days in the future in the United States with an averaged mean absolute percentage error of 27%. Being partly data-driven, the method is more accurate than typical mechanistic models and meanwhile more intuitive, and possibly reliable, than purely data-based machine learning models. Moreover, it can identify the most informative predictive variables, which can be helpful in designing improved forecasters as well as informing policymakers.


Full work available at URL: https://arxiv.org/abs/2112.04106




Recommendations




Cites Work


Cited In (10)





This page was built for publication: A hypothesis-free bridging of disease dynamics and non-pharmaceutical policies

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2127658)